Referencias bibliográficas

  1. Sun, W., et al. (2021). Schisandra chinensis, Five Flavor Berry, a Traditional Chinese Medicine and a Super-Fruit from North Eastern China. Pharmacognosy Communications, 11(1).
  2. Panossian, A., & Wikman, G. (2008). Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. Journal of ethnopharmacology, 118(2), 183–212.
  3. Jia, M., et al. (2023). An analysis of the nutritional effects of Schisandra chinensis components based on mass spectrometry technology. Frontiers in Nutrition, 10, 1227027.
  4. Yang, S., & Yuan, C. (2021). Schisandra chinensis: A comprehensive review on its phytochemicals and biological activities. Arabian Journal of Chemistry, 14(9), 103310.
  5. Panossian, A., et al. (2012). Adaptogens stimulate neuropeptide Y and Hsp72 expression and release in neuroglia cells. Frontiers in neuroscience, 6, 6.
  6. Xia, N., et al. (2016). Schisandra chinensis and Rhodiola rosea exert an anti-stress effect on the HPA axis and reduce hypothalamic c-Fos expression in rats subjected to repeated stress. Experimental and therapeutic medicine, 11(1), 353-359.
  7. Zhang, M., et al. (2018). Schisandra chinensis fructus and its active ingredients as promising resources for the treatment of neurological diseases. International Journal of Molecular Sciences, 19(7), 1970.
  8. Han, J., et al. (2019). Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II‐challenged vascular endothelium.Phytotherapy Research, 33(3), 779-790.
  9. Yan, T., et al. (2021). Schisandra chinensis protects against dopaminergic neuronal oxidative stress, neuroinflammation and apoptosis via the BDNF/Nrf2/NF-κB pathway in 6-OHDA-induced Parkinson’s disease mice. Food & function, 12(9), 4079-4091.
  10. Tan, L., et al. (2022). Schisandra chinensis (Turcz.) Baill. essential oil exhibits antidepressant-like effects and against brain oxidative stress through Nrf2/HO-1 pathway activation. Metabolic Brain Disease, 37(7), 2261-2275.
  11. Hassamal, S. (2023). Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories. Frontiers in psychiatry, 14, 1130989.
  12. Zhou, E., et al. (2014). Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways. International immunopharmacology, 22(1), 133-140.
  13. Zhao, T., et al. (2014). Schisandra polysaccharide evokes immunomodulatory activity through TLR 4-mediated activation of macrophages. International journal of biological macromolecules, 65, 33-40.
  14. Zefferino, R., et al. (2021). Molecular links between endocrine, nervous and immune system during chronic stress. Brain and behavior, 11(2), e01960.
  15. Yan, T., et al. (2021). Schisandra chinensis ameliorates depressive‐like behaviors by regulating microbiota‐gut‐brain axis via its anti‐inflammation activity.Phytotherapy Research, 35(1), 289-296.
  16. Zhao, et al. (2024). Schisandra chinensis lignans improve insulin resistance by targeting TLR4 and activating IRS-1/PI3K/AKT and NF-κB signaling pathways. International Immunopharmacology, 142, 113069.
  17. Panossian, A., & Wikman, G. (2009). Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Current clinical pharmacology, 4(3), 198-219.
  18. Yan, T., et al. (2016). Schisandra chinensis produces the antidepressant-like effects in repeated corticosterone-induced mice via the BDNF/TrkB/CREB signaling pathway. Psychiatry Research, 243, 135-142.
  19. Yuan, R., et al. (2018). Protective effect of acidic polysaccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress. Biomedicine & Pharmacotherapy, 99, 537-542.
  20. Wu, R., et al. (2018). The Cytochrome P450-mediated metabolism alternation of four effective lignans from schisandra chinensis in carbon tetrachloride-intoxicated rats and patients with advanced hepatocellular carcinoma. Frontiers in Pharmacology, 9, 229.
  21. Bansal, S., et al. (2024). Comprehensive Review on Schisandra chinesis. Pharmacological Research-Modern Chinese Medicine, 100406.
  22. Bansal, S., et al. (2024). Comprehensive Review on Schisandra chinesis. Pharmacological Research-Modern Chinese Medicine, 100406.
  23. Healy-Stoffel, M., & Levant, B. (2018). N-3 (Omega-3) fatty acids: effects on brain dopamine systems and potential role in the etiology and treatment of neuropsychiatric disorders. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 17(3), 216-232.
  24. Oravcova, H., et al. (2022). Stress hormones cortisol and aldosterone, and selected markers of oxidative stress in response to long-term supplementation with omega-3 fatty acids in adolescent children with depression. Antioxidants, 11(8), 1546.
  25. Backes, J., et al. (2016). The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids in Health and Disease, 15, 1-12.
  26. Yang, J., et al. J. (2019). Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation. Nutrients, 11(4), 872.
  27. Kim, D. S., et al. (2022). Efficacy and safety of Omija (Schisandra chinensis) extract mixture on the improvement of hyperglycemia: A randomized, double-blind, and placebo-controlled clinical trial. Nutrients, 14(15), 3159.
  28. Mozaffarian, D., & Wu, J. H. (2011). Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology, 58(20), 2047-2067.
  29. AbuMweis, S., et al. (2018). Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials.Journal of human nutrition and dietetics, 31(1), 67-84.
  30. Dusso, A. S., et al. (2005). Vitamin D. American journal of physiology. Renal physiology, 289(1), F8–F28.
  31. Patrick, R. P., & Ames, B. N. (2015). Vitamin D and the omega‐3 fatty acids control serotonin synthesis and action, part 2: Relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior.The FASEB Journal, 29(6), 2207-2222.
  32. Srichomchey, P., et al. (2023). Vitamin D3 supplementation promotes regulatory T-cells to maintain immune homeostasis after surgery for early stages of colorectal cancer. in vivo, 37(1), 286-293.